Loading chat...

WV HB5553

Bill

Status

Introduced

2/16/2026

Primary Sponsor

Josh Holstein

Click for details

Origin

House of Delegates

2026 Regular Session

AI Summary

  • Authorizes the Public Employees Insurance Agency (PEIA) and Department of Human Services to voluntarily participate in federal prescription drug pricing programs, including most-favored-nation and international reference pricing models

  • Permits participation through direct purchasing agreements with pharmaceutical manufacturers, federally negotiated pricing arrangements, or utilization of federal benchmark/ceiling prices for reimbursement

  • Requires participation only if the responsible agency determines it serves the state's best financial interest and does not reduce beneficiary access to medically necessary drugs

  • Preserves state authority to administer its own pharmacy benefits and does not require adoption of a federal formulary

  • Mandates annual reports to the Joint Committee on Government and Finance by December 1 detailing program participation, estimated cost savings, and any access or administrative issues identified

Legislative Description

Relating to participation in federal prescription drug pricing programs.

Health

Last Action

To House Health and Human Resources

2/16/2026

Committee Referrals

Health & Human Resources2/16/2026

Full Bill Text

No bill text available